Abbott reports positive results from study on its atrial fibrillation therapies

robot
Abstract generation in progress

Abbott announced positive results from studies on its Volt Pulsed Field Ablation system for treating atrial fibrillation, reinforcing its long-term safety and effectiveness. The Volt PFA System demonstrated a high success rate, with nearly 68% of patients remaining free from additional AFib episodes and a low repeat ablation rate. Additionally, Abbott presented positive results for its TactiFlex Duo Ablation Catheter, designed for tailored AFib therapy, further strengthening its commitment to advancing cardiac care.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)